The Anti-inflammatory Effects of HMGB1 Blockades in a Mouse Model of Cutaneous Vasculitis

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2020 Nov 2

PMID 33133061

Citations 5

Authors

Jin Wang

Lixin Fu

Hao Yang

Kai Cao

Qiaomei Sun

Tao Chen

Affiliations

Soon will be listed here.

Abstract

In our previous study, we have found increased serum levels of HMGB1 in patients with Henoch- Schonlein purpura (HSP), allergic vasculitis (AV), and urticarial vasculitis (UV) and altered HMGB1 distribution in lesional skin in patients with HSP. HMGB1 plays a pro-inflammatory role in the pathogenesis of HSP. To further investigate the role of HMGB1 in the pathogenic mechanism of vasculitis, we investigated the anti-inflammatory effects of HMGB1 blockades (including anti-HMGB1 mAb and glycyrrhizin) in a mouse model of a cutaneous reverse passive Arthus (RPA) reaction. A total of 36 balb/c mice were randomly divided into four groups: the control group, IC model group, HMGB1 monoclonal antibody (anti-HMGB1-mAb) group and the glycyrrhizin group, with nine mice in each group. A cutaneous RPA reaction mouse model was established by injections of the OVA antibody and the OVA antigen. Mice of the anti-HMGB1-mAb group and glycyrrhizin group were pre-treated with anti-HMGB1 mAb or glycyrrhizin, respectively, before the RPA reaction. Our results indicated that HMGB1 blockades (anti-HMGB1 mAb and glycyrrhizin) obviously extenuated the severity of vasculitis skin damage and improved the histological evolvement of inflammatory cells infiltration, vascular fibroid necrosis, and vasodilation in a cutaneous RPA reaction mouse model. In addition, HMGB1 blockades reduced the infiltration of neutrophils, DCs, and T cells and decreased the mRNA expression of IL-6 and CCL5 in skin lesions in the cutaneous RPA reaction mouse model. We suggest that HMGB1 blockades may represent a new direction for the treatment of cutaneous vasculitis.

Citing Articles

Role of HMGB1 in Vitiligo: Current Perceptions and Future Perspectives.

Wei G, Pan Y, Wang J, Xiong X, He Y, Xu J Clin Cosmet Investig Dermatol. 2022; 15:2177-2186.

PMID: 36267690 PMC: 9576603. DOI: 10.2147/CCID.S381432.

HMGB-1 in Psoriasis.

Casciaro M, Di Salvo E, Gangemi S Biomolecules. 2022; 12(1).

PMID: 35053208 PMC: 8774071. DOI: 10.3390/biom12010060.

Epigenetic Regulator KDM4D Restricts Tumorigenesis Modulating SYVN1/HMGB1 Ubiquitination Axis in Esophageal Squamous Cell Carcinoma.

Yao W, Wang J, Zhu L, Jia X, Xu L, Tian X Front Oncol. 2021; 11:761346.

PMID: 34820329 PMC: 8606580. DOI: 10.3389/fonc.2021.761346.

Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma.

Kam N, Wu K, Dai W, Wang Y, Yan L, Shakya R Angiogenesis. 2021; 25(2):181-203.

PMID: 34617194 PMC: 8494172. DOI: 10.1007/s10456-021-09819-0.

The Immune Tolerance Role of the HMGB1-RAGE Axis.

Watanabe H, Son M Cells. 2021; 10(3).

PMID: 33807604 PMC: 8001022. DOI: 10.3390/cells10030564.

References

Klune J, Dhupar R, Cardinal J, Billiar T, Tsung A . HMGB1: endogenous danger signaling. Mol Med. 2008; 14(7-8):476-84. PMC: 2323334. DOI: 10.2119/2008-00034.Klune. View

Andersson U, Wang H, Palmblad K, Aveberger A, Bloom O, Erlandsson-Harris H . High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000; 192(4):565-70. PMC: 2193240. DOI: 10.1084/jem.192.4.565. View

Carlson J . The histological assessment of cutaneous vasculitis. Histopathology. 2010; 56(1):3-23. DOI: 10.1111/j.1365-2559.2009.03443.x. View

Lee C, Park S, Kim Y, Kang S, Kim J, Lee S . Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice. Biol Pharm Bull. 2007; 30(10):1898-904. DOI: 10.1248/bpb.30.1898. View

Ming L, Yin A . Therapeutic effects of glycyrrhizic acid. Nat Prod Commun. 2013; 8(3):415-8. View

Lotze M, Tracey K . High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005; 5(4):331-42. DOI: 10.1038/nri1594. View

Chen T, Guo Z, Wang W, Qin S, Cao N, Li M . Increased serum HMGB1 levels in patients with Henoch-Schönlein purpura. Exp Dermatol. 2014; 23(6):419-23. DOI: 10.1111/exd.12422. View

Zhang S, Zhong J, Yang P, Gong F, Wang C . HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int J Clin Exp Pathol. 2009; 3(1):24-38. PMC: 2776260. View

Fauci A, Haynes B, Katz P . The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med. 1978; 89(5 Pt 1):660-76. DOI: 10.7326/0003-4819-89-5-660. View

10.

Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M . HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004; 5(8):825-30. PMC: 1299116. DOI: 10.1038/sj.embor.7400205. View

11.

Bustin M . Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol. 1999; 19(8):5237-46. PMC: 84367. DOI: 10.1128/MCB.19.8.5237. View

12.

Abraham E, Arcaroli J, Carmody A, Wang H, Tracey K . HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000; 165(6):2950-4. DOI: 10.4049/jimmunol.165.6.2950. View

13.

Orito H, Fujimoto M, Ishiura N, Yanaba K, Matsushita T, Hasegawa M . Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 cooperatively contribute to the cutaneous Arthus reaction. J Leukoc Biol. 2007; 81(5):1197-204. DOI: 10.1189/jlb.1006623. View

14.

Tang Z, Li T, Tong Y, Chen X, Chen X, Wang Y . A Systematic Review of the Anticancer Properties of Compounds Isolated from Licorice (Gancao). Planta Med. 2015; 81(18):1670-87. DOI: 10.1055/s-0035-1558227. View

15.

Chen T, Fu L, Guo Z, Yin B, Cao N, Qin S . Involvement of high mobility group box-1 in imiquimod-induced psoriasis-like mice model. J Dermatol. 2016; 44(5):573-581. DOI: 10.1111/1346-8138.13695. View

16.

Wang H, Bloom O, Zhang M, Vishnubhakat J, Ombrellino M, Che J . HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999; 285(5425):248-51. DOI: 10.1126/science.285.5425.248. View

17.

Chen T, Guo Z, Fu L, Cao N, Qin S . Anti-TWEAK monoclonal antibodies reduce vascular damage and leucocyte infiltration in a mouse model of cutaneous reverse passive Arthus reaction. Clin Exp Dermatol. 2016; 41(8):871-877. DOI: 10.1111/ced.12912. View

18.

Maeda S, Hikiba Y, Shibata W, Ohmae T, Yanai A, Ogura K . Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer. Biochem Biophys Res Commun. 2007; 360(2):394-400. DOI: 10.1016/j.bbrc.2007.06.065. View

19.

Yanaba K, Kaburagi Y, Takehara K, Steeber D, Tedder T, Sato S . Relative contributions of selectins and intercellular adhesion molecule-1 to tissue injury induced by immune complex deposition. Am J Pathol. 2003; 162(5):1463-73. PMC: 1851207. DOI: 10.1016/S0002-9440(10)64279-4. View

20.

Kim S, Jin Y, Shin J, Kim I, Lee H, Park S . Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion. Neurobiol Dis. 2012; 46(1):147-56. DOI: 10.1016/j.nbd.2011.12.056. View